India’s CDSCO Issues Compensation Formula for Trial-Related Deaths

Devices & Diagnostics Letter
Manufacturers conducting clinical trials in India would be required to pay significant compensation for deaths of some subjects during a study, under a rule released last week by the Central Drugs Standard Control Organization.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00